Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection-Reference-Cited by-同舟云学术

Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection

Published:2017-08-26 Issue:4 Volume:66 Page:1102-1110
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Wirth Stefan¹,Rosenthal Philip²,Gonzalez-Peralta Regino P.³,Jonas Maureen M.⁴,Balistreri William F.⁵,Lin Chuan-Hao⁶,Hardikar Winita⁷,Kersey Kathryn⁸,Massetto Benedetta⁸,Kanwar Bittoo⁸,Brainard Diana M.⁸,Shao Jiang⁸,Svarovskaia Evguenia⁸,Kirby Brian⁸,Arnon Ronen⁹,Murray Karen F.¹⁰,Schwarz Kathleen B.¹¹

Affiliation:

1. Helios Medical Center; Witten/Herdecke University; Wuppertal Germany

2. University of California San Francisco; San Francisco CA

3. University of Florida College of Medicine and Shands Children's Hospital; Gainesville FL

4. Boston Children's Hospital; Boston MA

5. Cincinnati Children's Hospital Medical Center; Cincinnati OH

6. Children's Hospital Los Angeles; Los Angeles CA

7. The Royal Children's Hospital Melbourne; Parkville VIC Australia

8. Gilead Sciences, Inc; Foster City CA

9. The Mount Sinai Hospital; New York NY

10. University of Washington School of Medicine and Seattle Children's Hospital; Seattle WA

11. Johns Hopkins University School of Medicine; Baltimore MD

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Reference26 articles.

1. Burden of pediatric hepatitis C;El-Shabrawi;World J Gastroenterol,2013

2. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012;Suryaprasad;Clin Infect Dis,2014

3. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012;Zibbell;MMWR Morb Mortal Wkly Rep,2015

4. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt;Frank;Lancet,2000

5. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease;Bortolotti;Gastroenterology,2008

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Sofosbuvir and Daclatasvir Treatment in Children and Adolescents With Thalassemia and Hepatitis C Virus Infection;Journal of Clinical and Experimental Hepatology;2024-05

2. ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource‐limited settings;Journal of Pediatric Gastroenterology and Nutrition;2024-02-18

3. Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children;Pathogens;2024-02-16

4. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysis;Liver International;2024-01-31

5. Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus infection;iLIVER;2023-09